Treatment of hereditary tyrosinaemia (fumarylacetoacetase deficiency) by enzyme substitution

  • B. Lindblad
  • J. Fridén
  • J. Greter
  • E. Holme
  • S. Lindstedt
  • C. Siösteen
Short Communication

Keywords

Exchange Transfusion Renal Tubular Damage Estimate Blood Volume Progress Liver Disease Blood Exchange Transfusion 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fällström, S. P., Lindblad, B., Lindstedt, S. and Steen, G. Hereditary tyrosinaemia — fumarylacetoacetase deficiency.Pediatr. Res. 13 (1979) 78CrossRefGoogle Scholar
  2. Holme, E., Lindblad, B. and Lindstedt, S. Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia.Lancet 1 (1985) 527PubMedCrossRefGoogle Scholar
  3. Kvittingen, E. A., Halvorsen, S. and Jellum, E. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinaemia.Pediatr. Res. 14 (1983) 541–544Google Scholar
  4. Lindblad, B., Lindstedt, S. and Steen, G. On the enzymic defects in hereditary tyrosinaemia.Proc. Natl. Acad. Sci. (USA) 74 (1977) 4641–4645PubMedCrossRefGoogle Scholar
  5. Weinberg, A. G., Mize, C. E. and Worthen, H. G. The occurrence of hepatoma in the chronic form of hereditary tyrosinaemia.J. Pediatr. 88 (1976) 434–438PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and MTP Press Limited 1986

Authors and Affiliations

  • B. Lindblad
    • 1
  • J. Fridén
    • 2
  • J. Greter
    • 2
  • E. Holme
    • 2
  • S. Lindstedt
    • 2
  • C. Siösteen
    • 3
  1. 1.Department of PediatricsMölndal's HospitalMölndalSweden
  2. 2.Department of Clinical ChemistryGothenburg University, Sahlgren's HospitalGothenburgSweden
  3. 3.Blood CentreSahlgren's HospitalGothenburgSweden

Personalised recommendations